back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-12-05 16:24 Tx date 2025-12-01 |
$MDP
Medexus Pharmaceuticals Inc. |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$47,700
+18,000 vol $2.65 each |
693,337 | |
| Filed 2025-12-05 16:23 Tx date 2025-12-01 |
$MDP
Medexus Pharmaceuticals Inc. |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-18,000 vol |
123,342 | |
| Filed 2025-12-05 16:23 Tx date 2025-12-01 |
$MDP
Medexus Pharmaceuticals Inc. |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
59 - Exercise for cash
|
-7,994 vol |
141,342 | |
| Filed 2025-12-05 16:22 Tx date 2025-12-01 |
$MDP
Medexus Pharmaceuticals Inc. |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+56,001 vol |
149,336 | |
| Filed 2024-12-10 16:46 Tx date 2023-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 6% Unsecured
38 - Redemption, retraction, cancellation, repurchase
|
-$40,000 vol |
$0 | |
| Filed 2024-11-21 16:07 Tx date 2024-11-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$18,964
+9,074 vol $2.09 each |
675,337 | |
| Filed 2024-11-21 16:07 Tx date 2024-11-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-9,074 vol |
93,335 | |
| Filed 2024-11-21 16:06 Tx date 2024-11-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
59 - Exercise for cash
|
-9,593 vol |
102,409 | |
| Filed 2024-11-20 16:30 Tx date 2024-11-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+56,001 vol |
112,002 | |
| Filed 2024-09-24 17:32 Tx date 2024-09-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,500
+3,000 vol $2.50 each |
666,263 | |
| Filed 2024-08-21 16:45 Tx date 2024-08-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
59 - Exercise for cash
|
-7,136 vol |
28,000 | |
| Filed 2024-08-21 16:44 Tx date 2024-08-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
-6,864 vol |
35,136 | |
| Filed 2024-08-21 16:43 Tx date 2024-08-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
59 - Exercise for cash
|
-7,136 vol |
||
| Filed 2024-08-21 16:43 Tx date 2024-08-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-6,864 vol |
||
| Filed 2024-08-21 16:29 Tx date 2024-08-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$15,993
+6,864 vol $2.33 each |
663,263 | |
| Filed 2024-08-21 16:29 Tx date 2024-08-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
59 - Exercise for cash
|
-7,136 vol |
||
| Filed 2024-08-21 16:28 Tx date 2024-08-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-6,864 vol |
||
| Filed 2024-06-28 17:09 Tx date 2024-06-28 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,000
+5,000 vol $1.80 each |
656,399 | |
| Filed 2024-06-28 17:08 Tx date 2024-06-27 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,750
+1,000 vol $1.75 each |
651,399 | |
| Filed 2023-11-15 15:01 Tx date 2023-11-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+56,001 vol |
56,001 |